tranexamic acid has been researched along with Cerebral Amyloid Angiopathy in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Cerebral Amyloid Angiopathy: A heterogeneous group of sporadic or familial disorders characterized by AMYLOID deposits in the walls of small and medium sized blood vessels of CEREBRAL CORTEX and MENINGES. Clinical features include multiple, small lobar CEREBRAL HEMORRHAGE; cerebral ischemia (BRAIN ISCHEMIA); and CEREBRAL INFARCTION. Cerebral amyloid angiopathy is unrelated to generalized AMYLOIDOSIS. Amyloidogenic peptides in this condition are nearly always the same ones found in ALZHEIMER DISEASE. (from Kumar: Robbins and Cotran: Pathologic Basis of Disease, 7th ed., 2005)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cerebral amyloid angiopathy is a devastating cause of intracerebral hemorrhage for which there is no specific secondary stroke prevention treatment." | 2.72 | Cerebral Amyloid Angiopathy and the Fibrinolytic System: Is Plasmin a Therapeutic Target? ( Cloud, GC; Keragala, CB; Markus, HS; Medcalf, RL; Mutimer, CA; Werring, DJ, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mutimer, CA | 1 |
| Keragala, CB | 1 |
| Markus, HS | 1 |
| Werring, DJ | 1 |
| Cloud, GC | 1 |
| Medcalf, RL | 1 |
1 review available for tranexamic acid and Cerebral Amyloid Angiopathy
| Article | Year |
|---|---|
Cerebral Amyloid Angiopathy and the Fibrinolytic System: Is Plasmin a Therapeutic Target?
Topics: Amyloid beta-Peptides; Antibodies, Monoclonal; Antifibrinolytic Agents; Cerebral Amyloid Angiopathy; | 2021 |